Alerts will be sent to your verified email
Verify Email
SMSPHARMA
|
SMS Pharmaceuticals
|
Aarti Drugs
|
Solara Active Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
2.4 % | 1.93 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
9.41 % | 18.02 % | -10.41 % |
|
5yr average Equity Multiplier
|
1.92 | 1.97 | 1.99 |
|
5yr Average Asset Turnover Ratio
|
0.64 | 1.09 | 0.54 |
|
5yr Avg Net Profit Margin
|
7.52 % | 8.24 % | -7.28 % |
|
Price to Book
|
4.07 | 2.38 | 1.98 |
|
P/E
|
35.14 | 17.58 | 388.38 |
|
5yr Avg Cash Conversion Cycle
|
95.74 Days | 79.88 Days | 28.67 Days |
|
Inventory Days
|
117.18 Days | 69.48 Days | 111.94 Days |
|
Days Receivable
|
94.73 Days | 111.3 Days | 95.97 Days |
|
Days Payable
|
94.13 Days | 97.75 Days | 146.85 Days |
|
5yr Average Interest Coverage Ratio
|
4.95 | 9.61 | 0.25 |
|
5yr Avg ROCE
|
12.07 % | 21.16 % | 2.1 % |
|
5yr Avg Operating Profit Margin
|
17.65 % | 14.01 % | 9.63 % |
|
5 yr average Debt to Equity
|
0.54 | 0.46 | 0.7 |
|
5yr CAGR Net Profit
|
2.03 % | -9.72 % | -69.98 % |
|
5yr Average Return on Assets
|
4.9 % | 9.12 % | -3.67 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
68.07 % | 55.03 % | 42.0 % |
|
Share Pledged by Promoters
|
17.99 % | 0.0 | 26.04 % |
|
Change in Promoter Holding (3 Yrs)
|
3.9 % | -4.63 % | 1.6 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.21 % | 6.21 % | -1.33 % |
|
SMS Pharmaceuticals
|
Aarti Drugs
|
Solara Active Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|